A new report titled “Nifedipine Market – Forecast to 2032” by Eternal Market, the global nifedipine industry is projected to grow at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2032, reaching a value of USD 1,834.7 million by the end of the forecast period.
Global Nifedipine Market Outlook
Nifedipine is a calcium channel blocker that is used to treat a variety of cardiovascular conditions, including hypertension, heart failure, and arrhythmias. It functions by letting go of the artery wall muscles, which lowers blood pressure and enhances blood flow. Nifedipine is also used to treat Raynaud’s phenomenon and premature labor. There are several dosage options for nifedipine, including pills, capsules, and extended-release tablets. With or without food, it is often taken once or twice day. Nifedipine dose varies according to the ailment being treated and the patient’s reaction to the drug.
Common side effects of nifedipine include headache, dizziness, and fatigue. Nifedipine is a prescription medication. It is not available over the counter. There are several forms of nifedipine, including capsules, extended-release pills, and immediate-release tablets. The precise indication and the intended duration of action both influence the formulation choice. In those with specific illnesses, including as severe hypotension (low blood pressure), heart failure, liver disease, renal disease, and a history of drug allergies, nifedipine should be taken with caution or avoided.
Global Nifedipine Market Forces
Increasing prevalence of chronic diseases is a significant driver behind the growth of the global nifedipine market.
Chronic conditions including hypertension, heart failure, and arrhythmias are becoming more prevalent worldwide. Cardiovascular disorders, the primary cause of mortality worldwide, are greatly increased by these illnesses. Since nifedipine is a successful therapy for many conditions, the market for nifedipine is anticipated to rise as these conditions become more common. A calcium channel blocker called nifedipine is used to treat heart failure, arrhythmias, hypertension, and other cardiovascular diseases. It functions by letting go of the artery wall muscles, which lowers blood pressure and enhances blood flow. Nifedipine is also used to treat Raynaud’s phenomenon and premature labor.
Growing awareness about the benefits of nifedipine is augmenting the growth of the global nifedipine market.
Nifedipine is an effective treatment for a variety of cardiovascular conditions, and it is also well-tolerated by most patients. The growing awareness about the benefits of nifedipine is expected to drive the growth of the nifedipine market. Since nifedipine is now available in generic form, a larger population may now afford and use the medicine. As a result, more people are aware of and use nifedipine to treat hypertension and angina. When taken correctly and under a doctor’s supervision, nifedipine has a well-established safety profile and has been used extensively for many years. The majority of adverse effects are modest and temporary, with flushes, headaches, and ankle edema being the most frequent ones.
Global Nifedipine Market Trends
Growing demand for generic nifedipine: Generic nifedipine is a cheaper alternative to brand-name nifedipine. As a result, there is a growing demand for generic nifedipine, which is driving the growth of the nifedipine market.
Increasing adoption of nifedipine in combination therapies: Nifedipine is increasingly being used in combination with other medications, such as beta-blockers and ACE inhibitors. This is leading to more effective and durable treatment outcomes for patients with hypertension and angina pectoris.
Global Nifedipine Market Segments
The global nifedipine market is segmented By Product (Nifedipine Controlled Release Tablets and Nifedipine Extended Action Tablets), By Applications (Primary Pulmonary Hypertension, Heart Failure, Raynauds Syndrome, Cephalagra, and Other Applications).
Based on deployment product, the nifedipine controlled release tablets, segment is expected to grow at the high rate during the forecast period. In 2022, the segment contributed around XX% of the overall market and expected to hold a share of XX% by 2031.
Nifedipine controlled-release pills are designed to distribute the drug into circulation gradually and steadily. Because of the constant therapeutic blood levels of nifedipine made possible by this prolonged release, angina and blood pressure management are maintained over a longer period of time. The tablets contain a matrix or coating that slowly dissolves or erodes, releasing the drug in a controlled manner. Nifedipine controlled-release tablets typically provide an extended duration of action, allowing for once-daily dosing in most cases. This convenience simplifies the medication regimen and improves patient adherence.
Based on applications, the heart failure, segment is expected to grow at the high rate during the forecast period. In 2022, the segment contributed around % of the overall market and expected to hold a share of XX% by 2031.
Nifedipine is a calcium channel blocker that is used to treat heart failure. It functions by reducing blood pressure and enhancing blood flow to the heart by relaxing the blood arteries. Although it is not a first-line therapy for heart failure, nifedipine may be utilized in some circumstances. Patients with high blood pressure and heart failure are the ones who utilize it the most frequently. Shortness of breath and weariness are two heart failure symptoms that nifedipine can help to alleviate. Additionally, it can lessen the chance of hospitalization and heart failure-related mortality. Angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta blockers, and mineralocorticoid receptor antagonists are typical medications used to treat heart failure. These drugs have shown promise in easing symptoms, enhancing heart function, and extending survival in heart failure patients.
Global Nifedipine Market Competitors
Key players operating in the global nifedipine market include AstraZeneca, Bayer, Boehringer Ingelheim, Pfizer, Sanofi, Teva Pharmaceutical Industries, Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Mylan, and Others.
Industry Developments:
March 2020: Pfizer announced that it had received approval from the FDA for its generic version of nifedipine. This approval will allow Pfizer to compete with the brand-name drug, Norvasc, which is currently the second-leading drug.
April 2020: Bayer announced that it had launched its nifedipine extended-release tablets in the U.S. The tablets are available in strengths of 10 mg, 20 mg, and 30 mg.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 31%
- Acquisitions: 15%
- New Product Launch: _%
- Other Developments: _%
Scope of the Report:
Global Nifedipine Market, by Product
- Nifedipine Controlled-Release Tablets
- Nifedipine Extended Action Tablets
Global Nifedipine Market, by Applications
- Primary Pulmonary Hypertension
- Heart Failure
- Raynauds Syndrome
- Cephalagra
- Other Applications
Global Nifedipine Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
-
- Brazil
- Argentina
- Rest of South America
-
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Pfizer
- Sanofi
- Teva Pharmaceutical Industries
- Aurobindo Pharma
- Reddy’s Laboratories
- Sun Pharmaceutical Industries
- Mylan
- Other Players
*The report scope shall be customized as per the requirements
Chapter 1 Global Nifedipine Market Overview
1.1 Introduction
1.2 Drivers for Nifedipine Market
1.3 Restraints for Nifedipine Market
1.4 Opportunities for Nifedipine Market
1.5 Trends for Nifedipine Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Nifedipine Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 AstraZeneca
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Bayer
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Boehringer Ingelheim
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Pfizer
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Sanofi
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Teva Pharmaceutical Industries
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Aurobindo Pharma
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Dr. Reddy’s Laboratories
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Sun Pharmaceutical Industries
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Mylan
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Nifedipine Market Overview
3.1 Global Nifedipine Market Outlook (2017-2032)
3.1.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Nifedipine Market by Region
3.2.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Nifedipine Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Nifedipine Market by Product
3.3.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
3.3.2 Global Nifedipine Market Attractiveness Analysis by Product, 2023–2032
3.3.3 Global Nifedipine Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Nifedipine Market by Application
3.4.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
3.4.2 Global Nifedipine Market Attractiveness Analysis by Application, 2023–2032
3.5 Global Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
3.6.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
3.6.2 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
3.7 Global Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
3.7.1 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
3.7.2 Global Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
3.8 Global Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Nifedipine Market Y-o-Y Growth Rate by Region
3.8.2 Global Nifedipine Market Y-o-Y Growth Rate by Product
3.8.3 Global Nifedipine Market Y-o-Y Growth Rate by Application
3.9 Global Nifedipine Market Share Comparison 2017–2032
3.9.1 Global Nifedipine Market Share by Region
3.9.2 Global Nifedipine Market Share by Product
3.9.3 Global Nifedipine Market Share by Application
Chapter 4 North America Nifedipine Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Nifedipine Market Outlook (2017-2032)
4.2.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Nifedipine Market by Region
4.3.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Nifedipine Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Nifedipine Market by Product
4.4.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
4.4.2 North America Nifedipine Market Attractiveness Analysis by Product, 2023–2032
4.4.3 North America Nifedipine Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Nifedipine Market by Application
4.5.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
4.5.2 North America Nifedipine Market Attractiveness Analysis by Application, 2023–2032
4.6 North America Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
4.7.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
4.7.2 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
4.8 North America Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
4.8.1 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
4.8.2 North America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
4.9 North America Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Nifedipine Market Y-o-Y Growth Rate by Region
4.9.2 North America Nifedipine Market Y-o-Y Growth Rate by Product
4.9.3 North America Nifedipine Market Y-o-Y Growth Rate by Application
4.1 North America Nifedipine Market Share Comparison 2017–2032
4.10.1 North America Nifedipine Market Share by Region
4.10.2 North America Nifedipine Market Share by Product
4.10.3 North America Nifedipine Market Share by Application
Chapter 5 Europe Nifedipine Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Nifedipine Market Outlook (2017-2032)
5.2.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Nifedipine Market by Region
5.3.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Nifedipine Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Nifedipine Market by Product
5.4.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
5.4.2 Europe Nifedipine Market Attractiveness Analysis by Product, 2023–2032
5.4.3 Europe Nifedipine Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Nifedipine Market by Application
5.5.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
5.5.2 Europe Nifedipine Market Attractiveness Analysis by Application, 2023–2032
5.6 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
5.7.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
5.7.2 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
5.8 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
5.8.1 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
5.8.2 Europe Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
5.9 Europe Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Nifedipine Market Y-o-Y Growth Rate by Region
5.9.2 Europe Nifedipine Market Y-o-Y Growth Rate by Product
5.9.3 Europe Nifedipine Market Y-o-Y Growth Rate by Application
5.1 Europe Nifedipine Market Share Comparison 2017–2032
5.10.1 Europe Nifedipine Market Share by Region
5.10.2 Europe Nifedipine Market Share by Product
5.10.3 Europe Nifedipine Market Share by Application
Chapter 6 Asia Pacific Nifedipine Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Nifedipine Market Outlook (2017-2032)
6.2.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Nifedipine Market by Region
6.3.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Nifedipine Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Nifedipine Market by Product
6.4.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
6.4.2 Asia Pacific Nifedipine Market Attractiveness Analysis by Product, 2023–2032
6.4.3 Asia Pacific Nifedipine Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Nifedipine Market by Application
6.5.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
6.5.2 Asia Pacific Nifedipine Market Attractiveness Analysis by Application, 2023–2032
6.6 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
6.7.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
6.7.2 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
6.8 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
6.8.1 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
6.8.2 Asia Pacific Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
6.9 Asia Pacific Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Nifedipine Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Nifedipine Market Y-o-Y Growth Rate by Product
6.9.3 Asia Pacific Nifedipine Market Y-o-Y Growth Rate by Application
6.1 Asia Pacific Nifedipine Market Share Comparison 2017–2032
6.10.1 Asia Pacific Nifedipine Market Share by Region
6.10.2 Asia Pacific Nifedipine Market Share by Product
6.10.3 Asia Pacific Nifedipine Market Share by Application
Chapter 7 South America Nifedipine Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Nifedipine Market Outlook (2017-2032)
7.2.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Nifedipine Market by Region
7.3.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Nifedipine Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Nifedipine Market by Product
7.4.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
7.4.2 South America Nifedipine Market Attractiveness Analysis by Product, 2023–2032
7.4.3 South America Nifedipine Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Nifedipine Market by Application
7.5.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
7.5.2 South America Nifedipine Market Attractiveness Analysis by Application, 2023–2032
7.6 South America Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
7.7.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
7.7.2 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
7.8 South America Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
7.8.1 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
7.8.2 South America Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
7.9 South America Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Nifedipine Market Y-o-Y Growth Rate by Region
7.9.2 South America Nifedipine Market Y-o-Y Growth Rate by Product
7.9.3 South America Nifedipine Market Y-o-Y Growth Rate by Application
7.1 South America Nifedipine Market Share Comparison 2017–2032
7.10.1 South America Nifedipine Market Share by Region
7.10.2 South America Nifedipine Market Share by Product
7.10.3 South America Nifedipine Market Share by Application
Chapter 8 Middle East and Africa Nifedipine Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Nifedipine Market Outlook (2017-2032)
8.2.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Nifedipine Market by Region
8.3.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Nifedipine Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Nifedipine Market by Product
8.4.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
8.4.2 Middle East and Africa Nifedipine Market Attractiveness Analysis by Product, 2023–2032
8.4.3 Middle East and Africa Nifedipine Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Nifedipine Market by Application
8.5.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
8.5.2 Middle East and Africa Nifedipine Market Attractiveness Analysis by Application, 2023–2032
8.6 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) by Product
8.7.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
8.7.2 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
8.8 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) by Application
8.8.1 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
8.8.2 Middle East and Africa Nifedipine Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
8.9 Middle East and Africa Nifedipine Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Nifedipine Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Nifedipine Market Y-o-Y Growth Rate by Product
8.9.3 Middle East and Africa Nifedipine Market Y-o-Y Growth Rate by Application
8.1 Middle East and Africa Nifedipine Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Nifedipine Market Share by Region
8.10.2 Middle East and Africa Nifedipine Market Share by Product
8.10.3 Middle East and Africa Nifedipine Market Share by Application
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
